Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Castle Biosciences, Inc. (CSTL)

20.95
-0.32
(-1.50%)
As of 2:57:37 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
332,069
332,069
219,788
137,039
94,085
Cost of Revenue
60,205
60,205
44,982
32,009
15,822
Gross Profit
271,864
271,864
174,806
105,030
78,263
Operating Expense
263,194
263,194
242,783
196,172
118,342
Operating Income
8,670
8,670
-67,977
-91,142
-40,079
Net Non Operating Interest Income Expense
12,339
12,339
10,612
3,951
67
Other Income Expense
555
555
--
18,287
--
Pretax Income
21,564
21,564
-57,365
-68,904
-40,012
Tax Provision
3,319
3,319
101
-1,766
-8,720
Net Income Common Stockholders
18,245
18,245
-57,466
-67,138
-31,292
Diluted NI Available to Com Stockholders
18,245
18,245
-57,466
-67,138
-31,292
Basic EPS
0.66
--
-2.14
-2.58
-1.24
Diluted EPS
0.62
--
-2.14
-2.58
-1.24
Basic Average Shares
27,776
--
26,802
26,054
25,137
Diluted Average Shares
29,255
--
26,802
26,054
25,137
Total Operating Income as Reported
8,670
8,670
-67,977
-72,855
-40,079
Total Expenses
323,399
323,399
287,765
228,181
134,164
Net Income from Continuing & Discontinued Operation
18,245
18,245
-57,466
-67,138
-31,292
Normalized Income
18,245
18,245
-57,466
-84,956.31
-31,292
Interest Income
12,916
12,916
10,623
3,968
68
Interest Expense
577
577
11
17
1
Net Interest Income
12,339
12,339
10,612
3,951
67
EBIT
22,141
22,141
-57,354
-68,887
-40,011
EBITDA
38,138
38,138
-45,024
-58,344
-36,604
Reconciled Cost of Revenue
55,314
55,314
41,665
29,732
14,373
Reconciled Depreciation
15,997
15,997
12,330
10,543
3,407
Net Income from Continuing Operation Net Minority Interest
18,245
18,245
-57,466
-67,138
-31,292
Total Unusual Items Excluding Goodwill
--
--
--
18,287
--
Total Unusual Items
--
--
--
18,287
--
Normalized EBITDA
38,138
38,138
-45,024
-76,631
-36,604
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
468.69
--
12/31/2021 - 7/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BDSX Biodesix, Inc.
0.5752
+16.16%
 
FLGT Fulgent Genetics, Inc.
18.90
0.00%
 
VCYT Veracyte, Inc.
31.97
+1.60%
 
CDNA CareDx, Inc
18.28
+2.47%
 
IDXG Interpace Biosciences, Inc.
1.0000
0.00%
 
RNVA Rennova Health, Inc.
0.0001
0.00%
 
AVCR.V Avricore Health Inc.
0.0550
+22.22%
 
GH Guardant Health, Inc.
46.59
+2.07%
 
TWST Twist Bioscience Corporation
39.82
+5.85%
 
IZOZF Izotropic Corporation
0.1650
0.00%